Taigen Biopharmaceutica Financials
| 4157 Stock | TWD 11.45 0.35 2.97% |
Taigen |
Understanding current and past Taigen Biopharmaceutica Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Taigen Biopharmaceutica's financial statements are interrelated, with each one affecting the others. For example, an increase in Taigen Biopharmaceutica's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Taigen Biopharmaceutica's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Taigen Biopharmaceuticals Holdings. Check Taigen Biopharmaceutica's Beneish M Score to see the likelihood of Taigen Biopharmaceutica's management manipulating its earnings.
| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| ISIN | KYG866171005 |
| Business Address | No 138, Xinming |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.taigenbiotech.com.tw |
| Phone | 886 2 8177 7020 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Taigen Biopharmaceutica without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Taigen Stock, because this is throwing your money away. Analyzing the key information contained in Taigen Biopharmaceutica's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Taigen Biopharmaceutica Key Financial Ratios
There are many critical financial ratios that Taigen Biopharmaceutica's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Taigen Biopharmaceutica reports annually and quarterly.Taigen Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Taigen Biopharmaceutica's current stock value. Our valuation model uses many indicators to compare Taigen Biopharmaceutica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Taigen Biopharmaceutica competition to find correlations between indicators driving Taigen Biopharmaceutica's intrinsic value. More Info.Taigen Biopharmaceuticals Holdings is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Taigen Biopharmaceutica's earnings, one of the primary drivers of an investment's value.Taigen Biopharmaceutica Systematic Risk
Taigen Biopharmaceutica's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Taigen Biopharmaceutica volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Taigen Biopharmaceutica correlated with the market. If Beta is less than 0 Taigen Biopharmaceutica generally moves in the opposite direction as compared to the market. If Taigen Biopharmaceutica Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Taigen Biopharmaceutica is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Taigen Biopharmaceutica is generally in the same direction as the market. If Beta > 1 Taigen Biopharmaceutica moves generally in the same direction as, but more than the movement of the benchmark.
Taigen Biopharmaceutica December 15, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Taigen Biopharmaceutica help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Taigen Biopharmaceuticals Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Taigen Biopharmaceuticals Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Taigen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Taigen Biopharmaceutica's daily price indicators and compare them against related drivers.
| Information Ratio | (0.27) | |||
| Maximum Drawdown | 9.62 | |||
| Value At Risk | (2.39) | |||
| Potential Upside | 2.08 |
Additional Tools for Taigen Stock Analysis
When running Taigen Biopharmaceutica's price analysis, check to measure Taigen Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taigen Biopharmaceutica is operating at the current time. Most of Taigen Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Taigen Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taigen Biopharmaceutica's price. Additionally, you may evaluate how the addition of Taigen Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.